Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
ASX Announcement
20 October 2025
CHANGE FINANCIAL LIMITED WEBSITE www.changefinancial.com ACN 150 762 351
REGISTERED ADDRESS: Suite 3E, Level 3, 340 Adelaide Street, Brisbane QLD 4000 POSTAL ADDRESS: GPO Box 1322, Brisbane QLD 4001
Notice of 2025 Annual General Meeting
20 October 2025 – Change Financial Limited (ASX: CCA) advises that its Annual General Meeting
for 2025 will held on Thursday, 20 November 2025 at 9.00 am (AEST – Brisbane time) (Meeting) at the
Office of Hopgood Ganim Lawyers, Level 8, Waterfront Place, 1 Eagle Street, Brisbane Queensland,
Australia.
Attached are copies of the following documents in relation to the Meeting:
• Letter to shareholders notifying the Meeting details
• Chairman’s Letter to shareholders summarising the agenda and setting out further
arrangements in relation to the Meeting
• Notice of 2025 Annual General Meeting
• Proxy Form (a personalised proxy form will be sent to each shareholder)
Authorised for release by the Board of Change Financial Limited.
About Change Financial
For more information, please contact:
Tony Sheehan
CEO
Change Financial Limited
investors@changefinancial.com
Tom Russell
Director
Change Financial Limited
investors@changefinancial.com
Change Financial Limited (ASX: CCA) (Change) is a global fintech, leveraging innovative and
scalable technology to provide tailored payment solutions, card issuing and testing to banks and
fintechs. Change’s technology is used by 150+ clients across 40+ countries to deliver simple,
flexible, and fast-to-market payment services, including card issuing and testing.
Change’s payments as a service (PaaS) platform Vertexon, seamlessly integrates with banks and
fintechs’ core systems enabling delivery of digital and virtual card solutions to their customers. It
includes integrated features such as Apple Pay, Google Pay, Samsung Pay and Buy Now Pay
Later (BNPL) services. Change currently manages and processes over 27 million credit, debit, and
prepaid cards worldwide.
Using PaySim, Change tests payment systems to help clients meet the reliability and performance
expectations of end customers. Simulating the full transaction lifecycle across multiple systems,
PaySim enables banks and fintechs to complete end-to-end testing of their payment platforms and
processes from a desktop. Change also provides the default standard for payments testing for
many Australian companies, including Australia’s domestic card payment service eftpos.
Learn more about Change at www.changefinancial.com
Notice is given that the Annual General Meeting (AGM or Meeting) of Shareholders of Change
Financial Limited ACN 150 762 351 (Company) will be held:
Date of Meeting: Thursday, 20 November 2025
Time of Meeting: 9.00 am (AEST)
Place of Meeting: Office of HopgoodGanim Lawyers, Level 8, Waterfront Place, 1 Eagle Street,
Brisbane, Queensland, Australia
Dear Shareholder,
Change Financial Limited – Annual General Meeting
Change Financial Limited (the Company) hereby announces its intention to hold its 2025 Annual
General Meeting (AGM or Meeting) of Shareholders at 9.00 am (AEST) on 20 November 2025. The
Meeting will be held at the Office of HopgoodGanim Lawyers, Level 8, Waterfront Place, 1 Eagle
Street, Brisbane, Queensland, Australia.
In accordance with section 110D of the Corporations Act 2001 (Cth) (Corporations Act), the
Company will not be sending hard copies of the Notice of Meeting (Notice) unless a Shareholder
has elected to receive documents in hard copy in accordance with the timeframe specified in
section 110E(8) of the Corporations Act.
The agenda of the Meeting will be to consider the following items of business:
• Receive and consider the Company’s 2025 Annual Report;
• Adoption of the 2025 Remuneration Report that was included in the 2025 Annual Report;
• Election of Director - Mr. Michael Giles;
• Re-election of Director - Mr. Ian Leijer;
• Re-election of Director - Mr. Tom Russell;
• Approval for the Company to issue Securities under the Performance Rights Plan;
• Approval for the grant of Executive Director Performance Rights; and
• Approval to issue an additional 10% of the issued capital of the Company over a 12-month
period pursuant to ASX Listing Rule 7.1A.
AGM Considerations and Shareholder Questions
A discussion will be held on all items to be considered at the AGM.
All Shareholders will have a reasonable opportunity to ask questions during the AGM. The Company
will endeavour to answer as many of the questions as practicable.
Shareholders who prefer to register questions in advance of the AGM are invited to do so. Written
questions must be received by the Company or MUFG Corporate Markets (AU) Limited by 9.00 am
(AEST) on Thursday, 20 November 2025, and can be submitted online, by mail, by fax or in person to
the Company or Link Market Services.
Questions for the auditor must be received in writing at least 5 business days before the AGM being
13 November 2025.
All Resolutions by Poll
Each of the resolutions proposed at the AGM will be decided on a poll. The Chair considers voting
by poll to be in the interests of the shareholders as a whole, and to ensure the representation of as
many Shareholders as possible at the meeting.
How to Vote
Please see the Notice of Meeting for details on Voting Entitlement, Proxy and Corporate
Representative Instructions.
We look forward to receipt of your completed Proxy form and any questions and comments you
wish to submit prior to the Meeting or otherwise your attendance and participation at the Meeting.
By order of the Board
Geoff Sam OAM
Chairman
20 October 2025
Notice of Annual General Meeting
and Explanatory Memorandum
Change Financial Limited
ACN 150 762 351
Date of Meeting: 20 November 2025
Time of Meeting: 9.00 am (AEST)
Place of Meeting: Office of HopgoodGanim Lawyers
Level 8, Waterfront Place, 1 Eagle Street, Brisbane, Queensland,
Australia
This is an important document and requires your attention
If you are in any doubt about how to deal with this document, please consult your legal,
financial or other professional advisor.
Explanatory Memorandum
2
PART A - AGENDA
Notice is given that the Annual General Meeting (AGM or Meeting) of shareholders of
Change Financial Limited ACN 150 762 351 (Company) will be held at HopgoodGanim
Lawyers, Level 8, Waterfront Place, 1 Eagle Street, Brisbane, Queensland on 20 November
2025 at 9.00 am (AEST).
Terms used in this Notice of Meeting are defined in Section 11 of the accompanying
Explanatory Memorandum.
1. ORDINARY BUSINESS
Financial Report
To receive and consider the Company’s Annual Report comprising the Directors’ Report
and Auditors’ Report, Directors’ Declaration, Statement of Financial Performance,
Balance Sheet, Statement of Cashflows and notes to and forming part of the accounts
for the Company and its controlled entities for the financial year ended 30 June 2025.
2. Resolution 1 – Adoption of Remuneration Report
To consider and, if thought fit, pass the following Resolution, with or without amendment,
as a non-binding advisory Resolution:
“That for the purposes of section 250R(2) of the Corporations Act and for all other
purposes, the Remuneration Report for the year ended 30 June 2025 (as set out in the
Directors' Report) is adopted.”
The vote on this Resolution 1 is advisory only and does not bind the Directors or the
Company.
Voting restriction pursuant to section 250R(4) of the Corporations Act
A vote on this Resolution 1 must not be cast (in any capacity) by or on behalf of either
of the following persons:
(a) a member of the Key Management Personnel (KMP) details of whose
remuneration are included in the Remuneration Report; and
(b) a Closely Related Party of such a member.
However, the above persons may cast a vote on Resolution 1 if:
(a) the person does so as a proxy; and
(b) the vote is not cast on behalf of a member of the KMP, details of whose
remuneration are included in the Remuneration Report, or a Closely Related
Party of such a member; and
(c) either:
(1) the voter is appointed as a proxy by writing that specifies the way the proxy
is to vote on the Resolution; or
(2) the voter is the Chair of the Meeting and the appointment of the Chair as
proxy:
A. does not specify the way the proxy is to vote on the Resolution; and
B. expressly authorises the Chair to exercise the proxy even if the
Resolution is connected directly or indirectly with the remuneration of a
Explanatory Memorandum
3
member of the KMP for the Company or, if the Company is part of a
consolidated entity, for the entity.
3. Resolution 2 – Election of Michael Giles as Director
To consider and, if thought fit, pass the following Resolution, with or without amendment,
as an Ordinary Resolution:
“That Michael Giles, a Director appointed as an additional Director and holding office
until the next general meeting of the Company after his appointment in accordance
with Rule 38.2 of the Company’s Constitution and ASX Listing Rule 14.4, be elected as a
Director of the Company.”
4. Resolution 3 – Re-election of Director- Mr. Ian Leijer
To consider and, if thought fit, pass the following Resolution, with or without amendment,
as an Ordinary Resolution:
“That Mr. Ian Leijer, who retires by rotation in accordance with Rule 40.6 of the
Company’s Constitution and ASX Listing Rule 14.4 and, being eligible, offers himself up for
re-election, be re-elected as a Director of the Company”.
5. Resolution 4 – Re-election of Director- Mr. Tom Russell
To consider and, if thought fit, pass the following Resolution, with or without amendment,
as an Ordinary Resolution:
“That Mr. Tom Russell, who retires by rotation in accordance with Rule 40.6 of the
Company’s Constitution and ASX Listing Rule 14.4 and, being eligible, offers himself up for
re-election, be re-elected as a Director of the Company”.
6. Resolution 5 – Approval for the Company to issue Securities under the Performance
Rights Plan
To consider and, if thought fit, pass the following Resolution, with or without amendment,
as an Ordinary Resolution:
“That, for the purposes of ASX Listing Rule 7.2 (Exception 13) and for all other purposes,
the Shareholders grant approval for the Company to issue securities under the
Performance Rights Plan (Plan) on the terms and conditions set out in the Explanatory
Memorandum accompanying this Notice."
Voting Exclusion Statement
The Company will disregard any votes cast in favour of this Resolution 5 by or on behalf
of:
• a person who is eligible to participate in the Plan; or
• an associate of those persons.
However, this does not apply to a vote cast in favour of this Resolution 5 by:
Explanatory Memorandum
4
• a person as a proxy or attorney for a person who is entitled to vote on the Resolution,
in accordance with directions given to the proxy or attorney to vote on the Resolution
in that way;
• the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on
the Resolution, in accordance with a direction given to the Chair to vote on the
Resolution as the Chair decides; or
• a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity
on behalf of a beneficiary provided the following conditions are met:
o the beneficiary provides written confirmation to the holder that the
beneficiary is not excluded from voting, and is not an associate of a person
excluded from voting, on the Resolution; and
o the holder votes on the Resolution in accordance with directions given by
the beneficiary to the holder to vote in that way.
Voting Restriction pursuant to Section 250BD of the Corporations Act – Resolution 5
As Resolution 5 is connected directly or indirectly with the remuneration of a member of
Key Management Personnel (KMP) for the Company, pursuant to section 250BD of the
Corporations Act, a person must not cast a vote, and the Company will disregard any
votes cast on this Resolution 5 by:
(a) any member of the KMP of the Company (or, if the Company is part of a
consolidated entity, of the entity); or
(b) a Closely Related Party of such KMP (or, if the Company is part of a consolidated
entity, of the entity),
who is appointed as a Shareholder’s proxy, on the basis of that appointment, where the
Shareholder does not direct in writing the way the proxy is to vote on this Resolution 5.
However, the Company need not disregard a vote if it is cast by the Chair of the
Meeting as proxy for a person who is entitled to vote, where the Shareholder does not
direct in writing the way the proxy is to vote on this Resolution 5, if the appointment of
proxy expressly authorises the Chair to exercise the proxy even if this Resolution 5 is
connected directly or indirectly with the remuneration of a member of the KMP for the
Company or if the Company is part of a consolidated entity, of the entity.
7. Resolution 6 - Approval for the grant of Executive Director Performance Rights
To consider and, if thought fit, pass the following Resolution, with or without amendment,
as an Ordinary Resolution:
“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders
approve the grant of 4,500,000 performance rights under the Company’s Performance
Rights Plan to Mr. Tom Russell, Executive Director, (or his nominee) (Executive Director
Performance Rights) on the terms set out in the Explanatory Memorandum”.
Voting exclusion statement pursuant to ASX Listing Rule 10.14
The Company will disregard any votes cast in favour of Resolution 6 by or on behalf of:
• a person referred to in ASX Listing Rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to
participate in the Performance Rights Plan, including Mr. Tom Russell; or
• any associate of that person or persons.
However, this does not apply to a vote cast in favour of Resolution 6 by:
Explanatory Memorandum
5
• a person as proxy or attorney for a person who is entitled to vote on Resolution 6 in
accordance with directions given to the proxy or attorney to vote on Resolution 6 in
that way;
• the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on
Resolution 6, in accordance with a direction given to the Chair of the Meeting to
vote on that resolution as the Chair of the Meeting decides; or
• a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
o the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting, and is not an associate of a person excluded from
voting, on Resolution 6; and
o the holder votes on that resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Proxy Appointment Restriction – Resolution 6
As Resolution 6 is connected directly or indirectly with the remuneration of a member of
Key Management Personnel (KMP) for the Company, pursuant to section 250BD of the
Corporations Act, the Company will disregard any votes cast on Resolution 6 by a member
of the KMP of the Company or their Closely Related Parties who has been appointed as a
proxy unless:
• the appointed proxy votes for a person who is permitted to vote and in
accordance with a direction on the proxy form (directed proxy); or
• the appointed proxy is the Chair of the Meeting and the appointment of the Chair
as proxy:
o does not specify the way the proxy is to vote on Resolution 6; and
o expressly authorises the Chair of the Meeting to exercise the proxy even if the
Resolution is connected directly or indirectly with the remuneration of a
member of the KMP.
8. SPECIAL BUSINESS
Resolution 7 - Approval to issue an additional 10% of the issued capital of the Company
over a 12-month period pursuant to ASX Listing Rule 7.1A
To consider and, if thought fit, pass the following Resolution, with or without amendment
as a Special Resolution:
“That, for the purposes of ASX Listing Rule 7.1A, and for all other purposes, Shareholders
approve the issue of Equity Securities of up to 10% of the issued capital of the Company
(at the time of issue) calculated in accordance with the formula prescribed in ASX Listing
Rule 7.1A.2, over a 12 month period from the date of the Meeting, at a price not less than
that determined pursuant to ASX Listing Rule 7.1A.3 and otherwise on the terms and
conditions described in the Explanatory Memorandum (Placement Securities).”
Important Note (in relation to Resolution 7)
The Company is not proposing to make an issue of equity securities under 7.1A.2 as at the
date of this Notice of Meeting. Accordingly, the proposed allottees of any Placement
Securities are not as yet known or identified. However, if that changes after the date of his
Explanatory Memorandum
6
Notice of Meeting, the Company will disregard any votes cast in favour of Resolution 7 by
or on behalf of:
• a person who is expected to participate in, or who will obtain a material benefit as
a result of, the proposed issue of Placement Securities; or
• any associate of that person or persons.
However, this does not apply to a vote cast in favour of Resolution 7 by:
• a person as proxy or attorney for a person who is entitled to vote on Resolution 7 in
accordance with directions given to the proxy or attorney to vote on Resolution 7 in
that way;
• the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on
Resolution 7, in accordance with a direction given to the Chair of the Meeting to
vote on that resolution as the Chair of the Meeting decides; or
• a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
o the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting, and is not an associate of a person excluded from
voting, on Resolution 7; and
o the holder votes on that resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
9. VOTING INTENTIONS OF CHAIR
Shareholders should be aware that any undirected proxies given to the Chair of the
Meeting will be cast by the Chair of the Meeting and counted in favour of Resolutions 1
to 7 (inclusive), subject to compliance with the Corporations Act. In exceptional
circumstances, the Chair of the Meeting may change their voting intention on these
Resolutions, in which case an ASX announcement will be made.
10. GENERAL BUSINESS
To consider any other business as may be lawfully put forward in accordance with the
Constitution of the Company.
By order of the Board
Adam Gallagher
Company Secretary
20 October 2025
Explanatory Memorandum
7
PART B – EXPLANATORY MEMORANDUM
1. Introduction
This Explanatory Memorandum is provided to shareholders of Change Financial Limited ACN
150 762 351 (Company) to explain the resolutions to be put to Shareholders at the Meeting to
be held at HopgoodGanim Lawyers, Level 8, Waterfront Place, 1 Eagle Street, Brisbane,
Queensland on 20 November 2025 at 9.00 am (AEST).
The purpose of this Explanatory Memorandum is to provide Shareholders with information that
is reasonably required by Shareholders to decide how to vote on the Resolutions. The
Company’s Notice of Annual General Meeting and this Explanatory Memorandum should be
read in their entirety and in conjunction with each other before making any decision in
relation to the resolutions.
Subject to the abstentions noted below, the Directors unanimously recommend that
Shareholders vote in favour of all Resolutions. The Chair of the Meeting intends to vote all
available undirected proxies in favour of each resolution.
Terms used in this Explanatory Memorandum are defined in Section 11.
2. Voting and Proxies
2.1. Entitlement to attend and vote
In accordance with regulation 7.11.37 of the Corporations Regulations 2001 (Cth), the
Board has determined that persons who are registered holders of shares of the Company
as at 7.00 pm (AEST) on 18 November 2025 will be entitled to attend and vote at the
Meeting as a shareholder.
If more than one joint holder of shares is present at the Meeting (whether personally, by
proxy or by attorney or by representative) and tenders a vote, only the vote of the joint
holder whose name appears first on the register will be counted.
2.2. Appointment of Proxy
Shareholders who are entitled to vote at the Meeting have a right to appoint a proxy to
attend the Meeting and vote on their behalf. The proxy need not be a Shareholder of
the Company and may be an individual or body corporate. If a Shareholder is entitled to
cast two or more votes, they may appoint two proxies and may specify the proportion or
number of votes each proxy is appointed to exercise. If the proxy appointments do not
specify a proportion or number, each proxy may exercise half of the Shareholder’s votes,
in which case any fraction of votes will be disregarded.
All Shareholders are invited and encouraged to participate in the Meeting and are
encouraged to lodge a directed Proxy Form to the Company in accordance with the
instructions noted in the Proxy Form. Lodgement of a Proxy Form will not preclude a
Shareholder from attending and voting at the Meeting.
Even if you plan to attend, you are encouraged to submit a Proxy Form before the
Meeting so that your vote can be counted if you cannot attend for any reason.
The proxy form must be signed by the member or the member’s attorney. Proxies given
by a corporation must be executed in accordance with the Corporations Act and the
constitution of that corporation.
Explanatory Memorandum
8
To be effective, the proxy must be received at the Share Registry of the Company no
later than 9.00 am (AEST) on Tuesday, 18 November 2025. Proxies must be received
before that time by one of the following methods:
By post: Change Financial Limited
C/- MUFG Corporate Markets (AU) Limited
Locked Bag A14
Sydney South NSW 1235
Australia
By facsimile: 02 9287 0309 (within Australia)
+61 2 9287 0309 (from outside Australia)
By delivery in person: MUFG Corporate Markets (AU) Limited*
Parramatta Square
Level 22, Tower 6
10 Darcy Street
Parramatta NSW 2150
Online: https://au.investorcentre.mpms.mufg.com/Login/Login
To be valid, a proxy form must be received by the Company in the manner stipulated
above. The Company reserves the right to declare invalid any proxy not received in this
manner.
2.3. Power of Attorney
A proxy form and the original power of attorney (if any) under which the proxy form is
signed (or a certified copy of that power of attorney or other authority) must be received
by the Company no later than 9.00 am (AEST) on Tuesday, 18 November 2025 being 48
hours before the Meeting.
2.4. Corporate Representatives
A body corporate which is a shareholder, or which has been appointed as a proxy, is
entitled to appoint any person to act as its representative in respect of the Meeting. The
appointment of the representative must comply with the requirements under section
250D of the Act. A “Certificate of Appointment of Corporate Representative” form may
be obtained from the Company’s share registry or online at:
https://au.investorcentre.mpms.mufg.com/Login/Login
IMPORTANT: If you appoint the Chair of the Meeting as your proxy, or the Chair becomes
your proxy by default, and you do not direct your proxy how to vote on each of the
resolutions then by submitting the proxy form you will be expressly authorising the Chair to
exercise your proxy on the resolutions, even though some of the resolutions are
connected, directly or indirectly, with approvals with respect to related parties or key
management personnel. The Chair presently intends to vote all undirected proxies
(where appropriately authorised) in favour of each item.
Explanatory Memorandum
9
2.5. Voting at the Meeting
It is intended that voting on each of the proposed resolutions at this Meeting will be
conducted by a poll, rather than on a show of hands. The results of the poll will be
determined following the close of the Meeting and lodged with the ASX Markets
Announcements Platform.
Shareholders are encouraged to submit a proxy vote ahead of the Meeting in
accordance with the Appointment of Proxy instructions above.
You can direct your proxy how to vote on a particular Resolution by marking the
appropriate box on the Proxy Form.
If you mark the abstain box for a particular Resolution, you are directing your proxy not to
vote on that item.
If you do not mark any particular Resolution and no direction is given, you are appointing
your proxy to vote as he or she decides, subject to any voting exclusions that may apply
to the proxy.
If you appoint a proxy, you may still attend the Meeting. However, your proxy’s rights to
speak and vote will be suspended while you are present.
2.6. ENCLOSURES
Enclosed are the following documents:
• Proxy Form to be completed if you would like to be represented at the Meeting by
proxy. Shareholders are encouraged to use the online voting facility that can be
accessed on Change Financial Limited’s share registry’s website at
https://au.investorcentre.mpms.mufg.com/Login/Login to ensure the timely and
cost-effective receipt of your proxy;
• a reply-paid envelope for you to return the Proxy Form if you do not wish to use the
online voting facility.
3. Consider the Company’s Annual Report
The Company’s Annual Report, comprising the Directors’ Report and Auditors’ Report,
Directors’ Declaration, Statement of Financial Performance, Balance Sheet, Statement of
Cashflows and notes to and forming part of the financial statements for the Company and its
controlled entities for the financial year ended 30 June 2025, was released to the ASX on 29
August 2025.
Shareholders can access a copy of the Company’s Annual Report at
www.changefinancial.com/investors/. The Company will not provide a hard copy of the
Company’s Annual Report to Shareholders unless specifically requested to do so.
The Company’s Annual Report is placed before the Shareholders for discussion.
No voting is required for this item.
Explanatory Memorandum
10
4. Resolution 1 - Adoption of Remuneration Report
4.1 Remuneration Report
The Board has submitted its Remuneration Report to Shareholders for consideration and
adoption by way of a non-binding advisory Resolution in accordance with section 250R of
the Corporations Act.
The Remuneration Report is set out on pages 8 to 18 of the Company’s Annual Report for the
period ending 30 June 2025. The Annual Report is available to download on the Company’s
website.
Under the Corporations Act, if at least 25% of the votes cast on the Resolution are voted
against the adoption of the Remuneration Report at two consecutive Annual General
Meetings, the Company will be required to put to shareholders a resolution at the second of
those Annual General Meetings proposing the calling of a General Meeting (Spill Meeting) to
consider the election of directors of the Company (Spill Resolution).
If more than 50% of shareholders vote in favour of the Spill Resolution, the Company must
convene the Spill Meeting within 90 days of the second Annual General Meeting. All of the
directors who were in office when the second (consecutive) Remuneration Report was
considered at the second (consecutive) Annual General Meeting, other than the Managing
Director, will cease to hold office immediately before the end of the Spill Meeting but may
stand for re-election at the Spill Meeting. Following the Spill Meeting, those persons whose
election or re-election as directors are approved will be the directors of the Company.
At the 2024 Annual General Meeting, less than 25% of the votes cast were voted against the
adoption of the Remuneration Report included in the 2024 Annual Report.
The Remuneration Report:
(a) explains the Board’s policy for determining the nature and amount of remuneration of
Key Management Personnel of the Company;
(b) explains the relationship between the Board’s remuneration policy and the
Company’s performance;
(c) sets out remuneration details for each Key Management Personnel of the Company,
including details of performance-related remuneration and options granted as part of
remuneration; and
(d) details and explains any performance conditions applicable to the remuneration of
Key Management Personnel of the Company.
A reasonable opportunity will be provided for discussion of the Remuneration Report at the
Meeting.
4.2 Directors’ Recommendation
The Directors abstain from making a recommendation regarding Resolution 1 as it concerns
the remuneration of KMP. In accordance with the Corporations Act, a vote on this resolution
is advisory only and does not bind the Directors or the Company.
4.3 Voting restrictions on Key Management Personnel and their Closely Related Parties and
their proxies
As set out in the notes to Resolution 1, a voting restriction statement applies with respect to
the voting on this Resolution by members of the Key Management Personnel and their Closely
Related Parties and their proxies voting (in any capacity) (Voting Restriction).
Explanatory Memorandum
11
Details of the restrictions on members of KMP and their Closely Related Parties and their
proxies voting (in any capacity) are set out in the voting restriction statement included in
Resolution 1 of the Notice of Meeting.
4.4 Chair’s Voting Intentions
Shareholders should be aware that any undirected proxies given to the Chairman will be cast
by the Chairman and counted in favour of this Resolution 1, subject to compliance with the
Corporations Act. In exceptional circumstances, the Chairman of the Meeting may change
his/her voting intention on any resolution, in which case an ASX announcement will be made.
5. Resolution 2 – Election of Michael Giles as Director
5.1 Background
As announced to the ASX on 31 March 2025, Mr. Michael Giles was appointed as a Non-
Executive Director effective 31 March 2025.
Rule 38.2 of the Company’s Constitution requires that any Director appointed under Rule 38.1
shall hold office only until the conclusion of the next following an
Share your feedback
Discover